Indication: 1. To supplement the lack of estrogen and treat female hypogonadism, amenorrhea, menopausal syndrome, etc.; used for the treatment of advanced breast cancer (postmenopausal women) and advanced prostate cancer; used in combination with progesterone drugs, it can inhibit ovulation and can be used as a contraceptive. It is mainly used clinically as an ovulation inhibitor; it is also used for cryptorchidism and androgen excess in children, pituitary tumors, etc. It is used to diagnose hypothalamic-adenohypophysial-gonadal dysfunction, which can be based on changes in gonadotropin and sex hormone levels. 2. To treat amenorrhea and infertility caused by hypogonadism due to insufficient secretion of gonadotropin, and infertility of multifollicular ovary. For amenorrhea related to weight loss, the weight should be corrected by diet first. It is also used for prostate cancer (often used in combination with cyproterone acetate or fluazifop), delayed or early puberty, and endometrial dysplasia. Main

Indication: 1. Early and late postmenopausal osteoporosis and senile osteoporosis where conventional estrogen combined with calcium preparations is contraindicated or cannot be used. 2. Hypercalcemia secondary to bone metastasis of breast cancer, lung cancer or kidney cancer, myeloma and other malignant tumors. 3. Osteitis deformans.

Indication: 1 Early and late postmenopausal osteoporosis and senile osteoporosis where conventional estrogen combined with calcium preparations is contraindicated or cannot be used. 2 Hypercalcemia secondary to bone metastasis of breast cancer, lung cancer or kidney cancer, myeloma and other malignant tumors. 3 Osteitis deformans.

Indication: 1 Early and late postmenopausal osteoporosis and senile osteoporosis where conventional estrogen combined with calcium preparations is contraindicated or cannot be used. 2 Hypercalcemia secondary to bone metastasis of breast cancer, lung cancer or kidney cancer, myeloma and other malignant tumors. 3 Osteitis deformans.

Indication: Non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.

Indication: Non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.

Indication: Non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.

Indication: Non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.

Indication: It is the main chemotherapy drug for malignant hydatidiform mole and choriocarcinoma. It is also used for adjuvant chemotherapy and palliative treatment of breast cancer, digestive tract tumors (including primary and metastatic liver cancer and pancreatic cancer), ovarian cancer and primary bronchial lung cancer. The ointment is used for skin cancer, vulvar leukoplakia, and chest wall metastasis of breast cancer.

Indication: It is the main chemotherapy drug for malignant hydatidiform mole and choriocarcinoma. It is also used for adjuvant chemotherapy and palliative treatment of breast cancer, digestive tract tumors (including primary and metastatic liver cancer and pancreatic cancer), ovarian cancer and primary bronchial lung cancer. The ointment is used for skin cancer, vulvar leukoplakia, and chest wall metastasis of breast cancer.